Skip to content
Home/Companies/Pharma/LifeCycle Pharma

LifeCycle Pharma

Pharma·Denmark·Exited 2006·Held 4yr
Entry
2002
Hold
4yr
Exit
2006

Who owns LifeCycle Pharma?

LifeCycle Pharma was owned by Nordic Biotech Advisors through Nordic Biotech K/S (2002 vintage) from 2002 to 2006, exited via IPO.

Hand-verified · updated 2026-08-18

Nordic Biotech Advisors
Investor
Nordic Biotech Advisors
Nordic Biotech K/S · 2002 · Life Sciences VC

Key facts

HQDenmark
SectorPharma
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2006

More from Nordic Biotech K/S

Other portfolio companies in the same fund.

Forward Pharma
Exited 2014
BiotechDenmark· 2006
Curalogic
Exited 2006
BiotechDenmark· 2004
Gastrotech Pharma
Active
BiotechDenmark· 2003
Osteologix
Exited 2006
BiotechDenmark· 2003

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track LifeCycle Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy LifeCycle Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on LifeCycle Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue